| Literature DB >> 31163580 |
Yanxiang Wang1,2, Haiwa Wu3, Zihao Wang4,5, Jingjing Zhang6, Jing Zhu7, Yifan Ma8, Zhaogang Yang9, Yuan Yuan10,11.
Abstract
Poly(glycerol sebacate) (PGS), a biodegradable elastomer, has been extensively explored in biomedical applications for its favorable mechanical properties and biocompatibility. Efforts have been made to fabricate multifunctional PGS copolymer in recent years, in particular PGS-co-PEG (poly(glycerol sebacate)-co-polyethylene glycol) polymers. However, rare research has been systematically conducted on the effect of reactant ratios on physicochemical properties and biocompatibility of PGS copolymer till now. In this study, a serial of PEGylated PGS (PEGS) with PEG content from 20% to 40% and carboxyl to hydroxyl from 0.67 to 2 were synthesized by thermal curing process. The effects of various PEGS on the mechanical strength and biological activity were further compared and optimized. The results showed that the PEGS elastomers around 20PEGS-1.0C/H and 40PEGS-1.5C/H exhibited the desirable hydrophilicity, degradation behaviors, mechanical properties and cell viability. Subsequently, the potential applications of the 20PEGS-1.0C/H and 40PEGS-1.5C/H in bone repair scaffold and vascular reconstruction were investigated and the results showed that 20PEGS-1.0C/H and 40PEGS-1.5C/H could significantly improve the mechanical strength for the calcium phosphate scaffolds and exhibited preferable molding capability for fabrication of the vascular substitute. These results confirmed that the optimized PEGS elastomers should be promising multifunctional substrates in biomedical applications.Entities:
Keywords: biodegradable elastomer; biomedical application; poly(glycerol sebacate) (PGS); polyethylene glycol (PEG)
Year: 2019 PMID: 31163580 PMCID: PMC6630889 DOI: 10.3390/polym11060965
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Feed ratio of the preparation of prepolymer PEGS.
| Pre-Polymer | Sample Code | Carboxyl/Hydroxyl | Feed |
|---|---|---|---|
|
| 20PEGS-0.67C/H | 2/3 | Glycerol 0.08 mol, PEG 0.02 mol, sebacic acid 0.093 mol |
| 20PEGS-1.0C/H | 1/1 | Glycerol 0.08 mol, PEG 0.02 mol, sebacic acid 0.14 mol | |
| 20PEGS-1.5C/H | 3/2 | Glycerol 0.08 mol, PEG 0.02 mol, sebacic acid 0.21 mol | |
| 20PEGS-2.0C/H | 2/1 | Glycerol 0.08 mol, PEG 0.02 mol, sebacic acid 0.28 mol | |
|
| 40PEGS-0.67C/H | 2/3 | Glycerol 0.03 mol, PEG 0.02 mol, sebacic acid0.045 mol |
| 40PEGS-1.0C/H | 1/1 | Glycerol0.03 mol, PEG 0.02 mol, sebacic acid 0.065 mol | |
| 40PEGS-1.5C/H | 3/2 | Glycerol 0.03 mol, PEG 0.02 mol, sebacic acid 0.0975 mol | |
| 40PEGS-2.0C/H | 2/1 | Glycerol 0.03 mol, PEG 0.02 mol, sebacic acid 0.13 mol |
Figure 1Synthetic process and characterization of PEGS prepolymer. (A) Prepolymer PEGS was synthesized by specific molar ratio via two-step polycondensation. (B) 1H-NMR spectra of prepolymer PEGS. (C) FT-IR spectra of prepolymer PEGS.
Theoretical and actual ratio of prepolymer PEGS.
| Sample | PEG Content % | Ratio (COOH/OH) | ||
|---|---|---|---|---|
| By 1H–NMR | Theoretical | By 1H–NMR | Theoretical | |
| 20PEGS-0.67C/H | 20.89 | 20 | 1.97/2.00 | 2.0/3.0 |
| 20PEGS-1.0C/H | 17.40 | 20 | 0.97/1.00 | 1.0/1.0 |
| 20PEGS-1.5C/H | 19.08 | 20 | 3.00/2.03 | 3.0/2.0 |
| 20PEGS-2.0C/H | 15.47 | 20 | 2.00/1.21 | 2.0/1.0 |
| 40PEGS-0.67C/H | 48.56 | 40 | 1.92/2.00 | 2.0/3.0 |
| 40PEGS-1.0C/H | 39.08 | 40 | 0.91/1.00 | 1.0/1.0 |
| 40PEGS-1.5C/H | 39.93 | 40 | 3.00/1.82 | 3.0/2.0 |
| 40PEGS-2.0C/H | 37.38 | 40 | 2.00/1.01 | 2.0/1.0 |
GPC result of prepolymer PEGS.
| Distribution Name | Mn (Daltons) | MWs (Daltons) | MP (Daltons) | PDI | |
|---|---|---|---|---|---|
| 20PEGS | PEGS-0.67C/H | 4355 | 6966 | 6124 | 1.599 |
| PEGS-1.0C/H | 5771 | 10,467 | 6577 | 1.814 | |
| PEGS-1.5C/H | 6203 | 11,516 | 6761 | 1.856 | |
| PEGS-2.0C/H | 4132 | 5548 | 2651 | 1.342 | |
| 40PEGS | PEGS-0.67C/H | 3264 | 4165 | 4931 | 1.276 |
| PEGS-1.0C/H | 4620 | 6934 | 5099 | 1.501 | |
| PEGS-1.5C/H | 5575 | 9433 | 6075 | 1.692 | |
| PEGS-2.0C/H | 3068 | 3213 | 3677 | 1.047 | |
Figure 2Curing process and crosslinking density of PEGS. (A) Prepolymer PEGS was cured at 130, 150 and 170 °C for 12 h and 36 h. (B) Gel content of PEGS elastomers cured at 150 °C. Asterisks indicate significant differences, * p < 0.05, ** p < 0.01, *** p < 0.005.
Figure 3Mechanical properties of PEGS. (A) Tensile stress-strain curves of PEGS elastomers. (B) Young’s modulus, (C) Tensile stress and (D) Tensile strain of PEGS elastomers. Asterisks indicate significant differences, * p < 0.05.
Mechanical properties of the PEGS elastomers.
| Sample Code | Tensile Stress (KPa) | Tensile Strain (%) | YM(KPa) |
|---|---|---|---|
| 20PEGS-0.67C/H | 599 ± 69 | 29 ± 6 | 516 ± 53 |
| 20PEGS-1.0C/H | 801 ± 103 | 30 ± 9 | 668 ± 111 |
| 20PEGS-1.5C/H | 670 ± 122 | 31 ± 5 | 547 ± 37 |
| 40PEGS-1.0C/H | 168 ± 43 | 23 ± 7 | 183 ± 78 |
| 40PEGS-1.5C/H | 359 ± 77 | 47 ± 8 | 191 ± 79 |
Figure 4Hydrophilicity and degradation behavior of PEGS elastomers. (A) Contact angle of PEGS elastomers. (B) In vitro and in vivo degradation of PEGS elastomers. Asterisks indicate significant differences, * p < 0.05, ** p < 0.01.
Figure 5Biocompatibility of PEGS elastomers. (A) MSCs cell viability on PEGS elastomers. (B) HUVECs cell viability on PEGS elastomers, Asterisks indicate significant differences, * p < 0.05, ** p < 0.01, *** p < 0.005. vs. the corresponding tissue culture plate (TCP) group).
Figure 6Biomedical application of PEGS. (A) PEGS/CaP composite scaffold with enhanced compression resistance (CaP and 20PEGS-1.0C/H/CaP for illustration). Scale bar: 1 cm (B) Compressive stress-strain curve of PEGS/CaP hybrid scaffolds. (C) Morphology of 20PEGS-1.0C/H and 40PEGS-1.5C/H tubes for potential vessel construction. Scale bar: 1 cm.
Mechanical properties of the PEGS/CaP scaffolds.
| Sample Code | Mechanical Strength (MPa) | Strain (%) | YM(MPa) |
|---|---|---|---|
| CaP | 1.5 ± 0.2 | 14.8 ± 0.7 | 3.2 ± 0.9 |
| 20PEGS-1.0C/H/CaP | 7.6 ± 0.2 | 16.5 ± 0.9 | 14.7 ± 1.1 |
| 40PEGS-1.5C/H/CaP | 4.9 ± 0.3 | 21.2 ± 0.5 | 7.4 ± 0.7 |